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Abstract
Object: Stereotactic body radiotherapy (SBRT) for vertebral metastases has emerged as a promising technique,
offering high rates of symptom relief and local control combined with low risk of toxicity. Nonetheless, local failure
or vertebral instability may occur after spine SBRT, generating the need for subsequent surgery in the irradiated
region. This study evaluated whether there is an increased incidence of surgical complications in patients previously
treated with SBRT at the index level.
Methods: Based upon a retrospective international database of 704 cases treated with SBRT for vertebral
metastases, 30 patients treated at 6 different institutions were identified who underwent surgery in a region
previously treated with SBRT.
Results: Thirty patients, median age 59 years (range 27–84 years) underwent SBRT for 32 vertebral metastases
followed by surgery at the same vertebra. Median follow-up time from SBRT was 17 months. In 17 cases,
conventional radiotherapy had been delivered prior to SBRT at a median dose of 30 Gy in median 10 fractions.
SBRT was administered with a median prescription dose of 19.3 Gy (range 15–65 Gy) delivered in median 1 fraction
(range 1–17) (median EQD2/10 = 44 Gy). The median time interval between SBRT and surgical salvage therapy was
6 months (range 1–39 months). Reasons for subsequent surgery were pain (n = 28), neurological deterioration
(n = 15) or fracture of the vertebral body (n = 13). Open surgical decompression (n = 24) and/or stabilization
(n = 18) were most frequently performed; Five patients (6 vertebrae) were treated without complications with
vertebroplasty only. Increased fibrosis complicating the surgical procedure was explicitly stated in one surgical
report. Two durotomies occurred which were closed during the operation, associated with a neurological deficit in
one patient. Median blood loss was 500 ml, but five patients had a blood loss of more than 1 l during the
procedure. Delayed wound healing was reported in two cases. One patient died within 30 days of the operation.
Conclusion: In this series of surgical interventions following spine SBRT, the overall complication rate was 19%,
which appears comparable to primary surgery without previous SBRT. Prior spine SBRT does not appear to
significantly increase the risk of intra- and post-surgical complications.
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Background
The skeleton is one of the most common sites of meta-
static disease spread in cancer patients with approxi-
mately 300,000 cases per year in the United States [1, 2].
Depending on the type of cancer, bony metastases occur
in up to 70% of patients [3]. Furthermore, the spine is
the most common site of bony metastasis, with post-
mortem detection of vertebral metastases in 30 to 36%
of patients who died from neoplastic disease [4–6].
Pain medication combined with conventional radio-
therapy (RT) is the standard of care for symptomatic
bone metastases. However, recent developments in RT
treatment planning and delivery enabled dose escalation
within one or few treatment sessions and thus stereotac-
tic body radiation therapy (SBRT) has emerged as a
promising treatment technique [7]. By offering high
rates of symptom relief and local control combined with
low rates of toxicity, its acceptance and use are increas-
ing [8, 9]. Nonetheless, symptomatic local failure or
spinal instability after spine SBRT may occur, generating
the need for subsequent surgery in the irradiated region
[10, 11].
Prior RT is known to cause tissue alterations which
might lead to difficult surgical conditions and subse-
quently to an increased risk of surgical complications.
On the contrary, single dose RT might also be used to
confine surgical induced fibrosis, which is common
practice in keloid surgery, but was also found beneficial
to prevent peridural fibrosis [12]. Surgical risk profiles
following SBRT have been described in case series for
recurrent tumors inside the lung [13, 14]. Despite fi-
brotic changes within the irradiated area, no increased
surgical toxicity due to previous SBRT was reported for
these cases. This study was conducted to specifically
evaluate whether there is an increased risk of intra- and
post-surgical complications after spine SBRT compared
to historical results of surgery without previous SBRT.
Methods
Based on a retrospective international database of 704
patients treated with SBRT for vertebral metastases at 7
centers, 30 patients were identified who underwent sur-
gery in a region previously treated with SBRT. Data for
32 surgical procedures, their treatment characteristics
and complications were available, covering a period from
November 2006 to July 2013. All centers are members of
the Elekta Spine Radiosurgery Research Consortium and
ethics approval was obtained by all institutions.
For each case the original surgical report was evalu-
ated regarding the localization, reason and type of sur-
gery, as well as intraoperative complications such as
increased tissue fibrosis or blood loss. Additionally, pa-
tient charts were screened for the following postopera-
tive complications: delayed wound healing (surgical site
infection and/or wound dehiscence), blood loss, spinal
instability, increased neurological deficit, pain, pneumo-
nia, deep vein thrombosis, pulmonary embolism, and
death within 30 days after surgery.
For plotting and statistical analyzes Microsoft Excel
2016 and R Studio 0.999 were used and next to descrip-
tive statistical figures, Shapiro Wilk-, Wilcoxon rank
sum-, Chi-Square- and Fishers exact test were applied.
To account for multiple testing p-values were adjusted
according to the false discovery rate approach [15].
Results
Thirty patients with a median age of 59 years (range 27–
84 years) underwent SBRT for 32 vertebral metastases
followed by surgery in the same region. Metastases of
breast cancer and kidney cancer accounted for more
than half of the cases. Median follow-up was 17 months
from date of SBRT and 8 months from date of surgery.
SBRT as well as conventional RT was exclusively deliv-
ered with Linear accelerators by Elekta. Doses for con-
ventional RT were prescribed to the 95%-isodose
according to ICRU 50/62. In constrast SBRT doses were
prescribed in-homogeneously to the PTV encompassing
isodose with variable maximum doses according to cen-
ter and treating physician. In 17 cases, conventional
radiotherapy had been delivered prior to SBRT at a me-
dian dose of 30 Gy in median 10 fractions. SBRT was
most frequently administered in a single fraction with a
median prescription dose of 18.4 Gy (median EQD2/
10 = 43.5 Gy). Fractionated SBRT used a median of
three fractions and a total dose of median 24 Gy (me-
dian EQD2/10 = 44 Gy). Overall, the median prescribed
physical and EQD2/10 doses were 19.3 Gy and 44 Gy,
respectively. Split into two groups of primary SBRT and
secondary SBRT, the latter with a history of conventional
RT in the same region, no significant difference was seen
according to patient characteristics, SBRT dose and frac-
tionation or surgical features. For a detailed assembly of
fractionation and dose schemes the reader is referred to
Tables 1 and 2.
The median time between SBRT and surgical salvage
therapy was 6 months (range 1–39 months). The most
frequent reason for surgery was progressive pain
(n = 28) followed by progressive neurological deterior-
ation (n = 15), fracture of the vertebral body (n = 13) or
in one case spondylolisthesis (see Fig. 1). Open surgical
decompression (n = 24) and/or stabilization using ped-
icle screws and rod fixation (n = 18) were the most fre-
quently performed surgical procedures. Vertebroplasty /
balloon kyphoplasty was performed 11 times in 10 pa-
tients, 5 of which in a combined approach with decom-
pression and placement of spinal instrumentation
devices (see Fig. 2).
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Due to different risks for vertebroplasty alone and
more complex surgery the patient population was di-
vided into two groups for risk analyzes.
Five patients were treated with vertebroplasty only and
formed the low-risk group. One patient was treated with
SBRT to T10 and T12 followed by simultaneous verteb-
roplasty at both sites 10 months later due to increased
pain and progressive vertebral body compression dem-
onstrated on imaging without complication. SBRT pre-
scription doses in this subgroup ranged from 15 to
24 Gy with 20.5 Gy in median in 1–3 fractions (median
EQD2/10 = 50 Gy). Two patients had conventional RT
prior to SBRT (40 Gy in 20 fr. / 30 Gy in 10 fr.). Overall,
none of these five patients suffered from any complica-
tion intra- or postoperatively except residual pain in two
cases.
Twenty-five patients in the high-risk group received
26 surgical salvage treatments. SBRT was delivered to a
median prescription dose of 18.4 Gy (15–65 Gy) in
mostly one fraction (1–17 fractions). Fifteen patients
had received conventional RT prior to SBRT: Eleven pa-
tients had received 30 Gy in 10 fractions, three patients
had received 20 Gy in 5 fractions and one patient had
received 35 Gy in 14 fractions. One patient was sequen-
tially treated in the L4 region starting with conventional
irradiation (30 Gy in 10 fractions) followed by SBRT
(19.4 Gy single fraction, time interval of 11 months),
surgical decompression (time interval of 5 months),
SBRT (17.6 Gy single fraction, time interval of 2 months)
and subsequent repeat surgical decompression (time
interval 8 months) without complications.
Intraoperatively, increased fibrosis complicating the
surgical procedure was explicitly stated in one out of 26
surgical reports leading to an unintentional durotomy
without further complications in this particular case. A
second patient with intraoperative durotomy experi-
enced an increased neurological deficit and delayed
wound healing after surgery. In both cases the durotomy
was sufficiently repaired during the surgical procedure
and no revision surgery was needed.
Information regarding blood loss during surgery was
available for 18 interventions. The median blood loss for
cases was 500 ml (range 5–2000 ml). Five patients expe-
rienced a blood loss of greater than 1 l during the pro-
cedure; in all five cases, an open decompressive surgery
in combination with stabilization devices was performed.
Two of these five patients had delayed wound healing,
and one patient died shortly after surgery. Furthermore,
four of these five patients had received prior conven-
tional fractionated RT in addition to SBRT at the treated
level. The finding of local complications occurring only
in the group of patients with conventional RT in
addition to SBRT was not statistically significant. No sig-
nificant differences were seen in this subgroup of pa-
tients in terms of primary site of disease, SBRT
prescription dose, and time interval between SBRT and
subsequent surgery.
Postoperatively, seven complications occurred which
are summarized in Table 3. Overall, two cases of delayed
wound healing were observed. One of these cases also
suffered from an increased postoperative neurological
deficit as already described. There was no case of subse-
quent spinal instability after surgery. Residual pain in
the surgical area was observed in eight patients. Three
patients had documentation of systemic complications:
one pneumonia, one urinary tract infection and deep
vein thrombosis, and one patient died shortly after the
Table 1 Patient and disease characteristics
Patient characteristics N = 30
Median age at Operation 59y (27–84)
Gender Females: 17 Males: 13
Primary site Number Percentage
Kidney 10 33%
Breast 7 23%
Prostate 3 10%
Melanoma 2 7%
NSCLC 1 3%
Colorectal 1 3%
Other 6 20%
Table 2 Available RT-characteristics of all SBRT, primary SBRT only, secondary SBRT only with a history of conventional RT in the
same region and conventional RT prior to SBRT
SBRT over all Primary SBRT Secondary SBRT Prior conventional RT
Number of
treatments
Median prescription
dose (range)
Number of
treatments
Median prescription
dose (range)
Number of
treatments
Median prescription
dose (range)
Number of
treatments
Median prescription
dose (range)
Over all 32 19,3 (15–65) 15 21.7 Gy (15.7–65 Gy) 17 18 Gy (15–24 Gy) 16 30 Gy (20–40 Gy)
1 fraction 25 18,4 Gy (15–24 Gy) 10 20.5 Gy (15.7–24 Gy) 15 18 Gy (15–20 Gy) 3 20 Gy in 5 fractions
2 fractions 3 24 Gy 2 24 Gy 1 24 Gy 11 30 Gy in 10 fractions
3 fractions 2 17,7 Gy (15–20,4 Gy) 1 20.4 Gy 1 15 Gy 1 35 Gy in 14 fractions
5 fractions 1 25 Gy 1 25 Gy 1 40 Gy in 20 fractions
17 fractions 1 65 Gy 1 65 Gy
Roesch et al. Radiation Oncology  (2017) 12:153 Page 3 of 8
surgical procedure due to causes that could not be
determined.
Discussion
This study evaluated the risks of in-field spine surgery
subsequent to SBRT. It is well documented that the
overall complication rate associated with palliative spinal
surgery in oncological patients is high. Due to their ma-
lignant disease and often multiple local and systemic
therapies, cancer patients frequently suffer from multiple
risk factors for both local as well as systemic intraopera-
tive and postoperative complications. In the current
study, we observed an overall surgical complication rate
of 19% for the high risk group. Despite heterogeneous
definitions and grouping of complications among
previously published reports, this risk does not appear to
be increased compared to series of surgical complica-
tions in comparable patients who undergo surgery with-
out prior SBRT [16–19]. Regarding systemic
complications, our rates of pneumonia (4%) and deep
vein thrombosis (4%) are also within the expected range.
In this cohort, one patient died within 30 days following
surgery (4%) and similar mortality rates ranging from 3%
to 13% have been reported in several retrospective and
prospective surgical series [16–18, 20–23].
Regarding local complications, general risk factors such
as age, stress, diabetes, medication, drugs, nutritional sta-
tus or extent and duration of surgery have been described
[24]. Explicitly in spinal surgery, a preoperative neuro-
logical deficit resulting from close proximity of the tumor
to neural structures is a factor further increasing the risk
for surgical complications [25, 26]. In a large retrospective
study including almost 1000 patients by Finkelstein et al.,
a preoperative neurological deficit contributed to a 19%
increase in mortality and a 71% increase in the risk of
postoperative wound infection [16]. With 15 procedures
undertaken due to progressive neurological deficit, pa-
tients with this risk factor were overrepresented in our
study. However, postoperative complications were equally
distributed amongst both of the subgroups.
Fibrotic tissue alteration after RT and SBRT is a well-
known phenomenon. Therefore, this alteration might
lead to difficult surgical conditions and to an increased
risk of surgical complications. Surgical risk profiles fol-
lowing SBRT have been described in case series for re-
current tumors inside the lung [13, 14]. Despite fibrotic
change within the irradiated area, no increased surgical
morbidity due to previous SBRT was reported in these
series of lung surgery. Regarding the time interval be-
tween irradiation and subsequent surgery, fibrotic re-
modeling inside the lung caused by SBRT seems to take
place up to 1 year until reaching its maximum [27].
The evidence for increased fibrosis after spine SBRT is
limited. By using radiosurgical doses of 10 Gy and 20 Gy
in a mouse model, the extent and severity of epidural fi-
brosis after irradiation was shown to be dose and time
dependent [28]. In our series only one surgical report
explicitly mentioned complicating surgical conditions
due to fibrotic remodeling. Additional cases with in-
creased fibrosis but not complicating the surgical pro-
cedure may be assumed, but were not stated. In this
context, two cases of durotomy and intraoperative cere-
brospinal fluid leakage were observed which corresponds
to a crude rate of 6.3% in 32 surgical sites. Durotomy
may be associated with increased perioperative morbid-
ity and long-term neurological sequelae [29]. According
to large single institution series accidental durotomy oc-
curs in 3.6–7.6% in primary spine surgery but its inci-
dence increases in lumbar location or patients with pre-
Fig. 1 Venn diagram illustrating the reason for surgery:
fracture = red circle, neurological deficit = green circle,
pain = yellow circle
Fig. 2 Venn diagram illustrating the type of surgery:
decompression = red circle, stabilization = green circle,
vertebroplasty = yellow circle
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existing fibrosis, which is best validated for revision sur-
gery [30–34]. For total en bloc spondylectomy, preopera-
tive conventional RT was a dose and time dependent
risk factor for durotomy [35]. The authors reported an
increased complication rate above 40 Gy or after a time
interval of 1 year between RT and surgery.
Intraoperative blood loss correlates with the extent of
surgery, leads to increased stress of the cardiovascular sys-
tem and might require blood transfusions. Furthermore, it
is associated with an increased wound infection rate [36].
In general, blood loss exceeding 2000 ml is uncommon in
spinal surgery [33]. In our patient cohort we observed a
median blood loss of 500 ml (range 5–2000 ml). Five pa-
tients lost more than 1 l of blood during the operation. This
large variability in blood loss is most likely explained by the
variety of surgical interventions performed in our study
ranging from percutaneous instrumental stabilization to
wider tumor resections partly combined with stabilization.
Shehadi et al. reported a median blood loss of 500 ml in an-
terior or posterior approach only, 1350 ml for the com-
bined simultaneously, and 2500 ml for the combined
staged approach [37]. Similarly, Quan et al. reported a
mean blood loss of 718 ml for surgeries with both anterior
and posterior approaches [21]. In the series reported by
Demura et al., a median blood loss of 1560 ml was seen,
but only one quarter of patients received palliative surgery.
In the majority of patients en bloc spondylectomy or vast
debulking was performed. Likewise, Wang et al. reported a
median blood loss of 1500 ml during their interventions
where the spinal cord was circumferentially decompressed
by a posterolateral transpedicular approach [38].
Conventional RT is a known risk factor for postopera-
tive wound healing complications, like wound dehis-
cence or infection, in different organ sites including the
spine [26, 39, 40]. Several large retrospective series re-
ported increased rates of surgical site infections of 12–
40% in pre-irradiated tissue compared to only 1–15%
without prior RT [21, 25, 41–44]. Another smaller series
of 42 patients reported two wound breakdowns after revi-
sion surgery and one wound infection in pre-irradiated
patients [45]. However, one must be aware of a possible
negative selection bias and poor description of RT regard-
ing dose and interval between surgery and RT within this
retrospective data. On the contrary, some studies could
not confirm this relationship. Shehadi et al. retrospectively
and Wang et al. prospectively could not find an associ-
ation between preoperative irradiation and postoperative
wound infection [37, 38]. In the latter, 60% of 140 patients
were irradiated before surgery with mostly 30 Gy in 10
fractions and an interval between RT and surgery of more
than 30 days. Table 4 summarizes studies analyzing surgi-
cal complications after spine surgery.
Whether there is a dose-effect relationship for surgical
complications following radiotherapy remains unclear.
Most studies reporting post-surgical wound healing issues
described characteristics of radiotherapy only poorly. On
the other hand, studies with an emphasis on radiation on-
cology often do not report surgical outcome or complica-
tions. Nonetheless, there is some clinical and preclinical
data suggesting a dependency between RT-dose and post-
operative wound complication rate [46]. Further conclu-
sions by analogy can be drawn from other treatment sites.
Single fraction doses of up to 7 Gy are frequently and safely
administered immediately prior to surgery to reduce the
risk for heterotopic ossification [47, 48]. Complication rates
increase after preoperative conventionally fractionated
radiotherapy of 50 Gy and further increase with an add-
itional boost in sarcoma treatment [49]. Likewise, Yoko-
gawa et al. reported a tendency for more frequent wound
complications after spinal surgery for patients pretreated
with >40 Gy [35]. The interval between surgery and RT
might also be an important risk factor for post-surgical
wound healing complications. Irradiation interferes with
immediate wound healing in the short term and favors fi-
brotic tissue alterations in the long term. To minimize the
risk of radiotherapy-induced wound complications,
Table 3 Systemic, local and overall complication rate for 26 surgical interventions (open surgical decompression and/or
instrumental stabilization) at 25 sites in 25 patients with previous conventional RT and SBRT or SBRT only at the same level
Overall (n = 26) RT + SBRT (n = 15) SBRT (n = 11)
Systemic complications 4 (in 3 patients = 12%) 1 (7%) 3 (in 2 patients = 27%)
Pneumonia / urinary tract infection 1 / 1 0 1 / 1
Deep vein thrombosis 1 0 1
Perioperative death (within 30 days) 1 1 0
Local complications 3 (in 2 patients = 8%) 3 (in 2 patients = 13%) 0
Increased neurological deficit 1 1 0
Spinal instability 0 0 0
Delayed wound healing 2 2 0
Postoperative bleeding/Hematoma 0 0 0
Overall complication rate 7 (in 5 patients = 19%) 4 (in 3 patients = 17%) 3 (in 2 patients = 27%)
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recommendations regarding the right point in time for
surgery following RT range between an absolute mini-
mum of one to 3 weeks [43, 46, 50]. However, such plan-
ning is not always possible in the situation of the need for
urgent surgery.
The issue of wound complications in patients who under-
went spine surgery for metastasis with a history of prior
radiotherapy was studied by Keam et al. [51]. In their series
of 165 patients 35 patients received hypofractionated RT
with doses of 18–30 Gy in 1–5 fractions. The 6-month cu-
mulative incidence of wound complications for conventional
RT was 17% and for hypofractionated RT was 6%. There
was no significant difference, but a tendency for higher
doses per fraction being associated with lower wound com-
plication rates.
In our setting of surgery after SBRT, we observed delayed
wound healing in two cases, corresponding to a crude rate
of 8%, which is in the range of large surgical spine series of
7–12% [16, 21, 25, 38]. Furthermore, local complications
were only seen in patients with prior history of conventional
RT in addition to stereotactic RT supporting the thesis of
Keam et al. A possible explanation for lower risk after SBRT
despite higher biologically effective radiation doses com-
pared to conventional palliative radiotherapy may be given
by a more conformal dose distribution reducing the affected
tissue to a minimum.
The favorable outcome in our study might be explained
by the high level of radiotherapy and neurosurgical
experience and expertise of all participating centers. All
institutions have a clinical and scientific focus on the
multi-disciplinary treatment of vertebral metastases. Add-
itionally, SBRT and salvage surgery were performed at the
same institution in all cases: this guarantees the best ac-
cess of the neurosurgeon to all the relevant information of
the previous SBRT treatment which might be beneficial
for patient selection and planning of the surgical proced-
ure. Still, expected complications were seen in this study.
Bearing this in mind our results may not be assignable to
centers with less expertise.
The relative small number of highly selected cases and
its retrospective type are major limitations of this study.
Therefore, statistical analyzes are to be treated with cau-
tion. Heterogeneity and missing details of surgical proce-
dures like blood loss reflects the data’s origin from a
multicenter database. Furthermore, heterogeneous defi-
nitions of complications among different studies may
impede an actual comparison.
Conclusion
Based on the results of this multi-institutional study,
surgery in a specialized center appears to be a safe sal-
vage option in case of symptomatic local tumor recur-
rence or spinal instability after spine SBRT. The rate of
complications does not appear to be higher compared to
series without prior SBRT or series with prior conven-
tional radiotherapy.
Table 4 Summary of trials with general and local complication rates after spine surgery with and without previous RT
Study, year Main type of surgery Complications rate Wound complications Perioperative
deaths = 30 days
mortality
Overall /
Number of
patients
RT + S /
number of
patients
S alone /
number of
patients
overall /
number of
surgeries
RT + S /
number of
surgeries
S alone /
number of
surgeries
Demura,
2009 [41]
Debulking /
stabilization
– – – 7.1% / 113 31.8% / 22 1.1% / 91 –
Ghogawala,
2001 [43]
Posterolateral
decompression and
stabilization
/ 85 – – – 32% / 28 12% / 34 –
Lau, 2013
[34]
– 21.7% / 106 23.5% / 81 16% / 25 3.8%/106 – – 1 (0.9%)
Pascal, 1998
[25]
Post + ant. approach 18.6% / 145 – – 11% / 145 12% 1% 3 (2%)
Quan, 2011
[21]
Post + ant. approach 26% / 118 42% / 19 – 6.8% / 118 15.8% / 19 5% / 99 9 (7.6%)
Shehadi,
2007 [37]
– – – 39% / 87 – No significant difference –
Sundaresan,
2002 [42]
Ant. Approach +
post. stab.
80 15% / 40 40% / 40 13.8% / 80 25% / 40 2.5% / 40 1 (1.3%)
Wang, 2004
[38]
Posterior approach 14.3% / 140 84 56 11.4% / 140 No significant difference 6 (4.3%)
Wise, 1999
[26]
Post + ant. approach 25% / 80 15.5% / 41 9.3% /39 17.1% / 80 – – 2 (2.3%)
Yokogawa,
2014 [35]
Total en bloc
spondylectomy
40% / 50 77.8% / 18 18.8% / 32 8% / 50 22.2% / 18 0% / 32 –
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